|
|
|
Insider
Information: |
Makower Joshua |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
19 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
121,909,609 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$396,036,358 |
|
|
Total
Shares |
121,909,609 |
|
|
Total
Value |
$396,036,358 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
14.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nuvelo Inc |
ABIO |
10% Owner |
|
0 |
2018-02-26 |
0 |
Premium* |
|
Ardelyx Inc |
ARDX |
10% Owner |
|
0 |
2019-12-09 |
6,564,372 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
|
0 |
2020-06-19 |
3,952,958 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
|
0 |
2016-12-19 |
5,215,128 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
|
0 |
2018-03-09 |
0 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2020-07-24 |
10,376,936 |
Premium* |
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2020-04-03 |
5,937,998 |
Premium* |
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
4,186,243 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2020-06-30 |
4,294,207 |
Premium* |
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
0 |
2020-07-14 |
2,902,115 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
2,437,689 |
Premium* |
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2020-09-18 |
3,060,527 |
Premium* |
|
Eargo, Inc. |
EAR |
Director, 10% Owner |
2020-10-20 |
0 |
2021-05-24 |
508 |
Premium* |
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
|
0 |
2021-06-08 |
2,285 |
Premium* |
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2021-03-15 |
24,137,931 |
Premium* |
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
Bright Health Group Inc. |
BHG |
10% Owner |
|
0 |
2021-06-28 |
23,983,073 |
Premium* |
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARDX |
Ardelyx Inc |
10% Owner |
|
2015-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,803,738 |
|
- |
|
ABIO |
Nuvelo Inc |
10% Owner |
|
2015-06-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,221,465 |
|
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2016-05-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,362,694 |
|
- |
|
AKAO |
Achaogen Inc |
10% Owner |
|
2016-06-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,715,128 |
|
- |
|
CASC |
Cascadian Therapeutics, I... |
10% Owner |
|
2017-01-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,064,574 |
|
- |
|
RGLS |
Regulus Therapeutics Inc. |
10% Owner |
|
2017-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,989,010 |
|
- |
|
DM |
Desktop Metal Ord Shs Cla... |
10% Owner |
|
2020-12-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
28,398,927 |
|
- |
|
SVRA |
Savara Inc |
10% Owner |
|
2021-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
24,137,931 |
|
% |
|
BHG |
Bright Health Group Inc. |
10% Owner |
|
2021-06-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
46,859,421 |
|
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2016-01-13 |
4 |
B |
$10.00 |
$10,000,000 |
I/I |
1,000,000 |
1,901,869 |
1.5 |
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2016-07-18 |
4 |
B |
$8.73 |
$13,333,338 |
I/I |
1,527,301 |
2,665,519 |
1.5 |
- |
|
AKAO |
Achaogen Inc |
10% Owner |
|
2016-12-19 |
4 |
B |
$13.50 |
$6,750,000 |
I/I |
500,000 |
5,215,128 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2017-03-28 |
4 |
B |
$0.50 |
$3,000,000 |
I/I |
6,000,000 |
16,362,694 |
1.5 |
- |
|
CASC |
Cascadian Therapeutics, I... |
10% Owner |
|
2018-02-20 |
4 |
OE |
$3.30 |
$5,999,400 |
I/I |
1,818,000 |
10,882,574 |
0 |
- |
|
ABIO |
Nuvelo Inc |
10% Owner |
|
2018-02-26 |
4 |
S |
$0.50 |
$731,273 |
I/I |
(1,460,209) |
0 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
10% Owner |
|
2018-03-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,882,574) |
0 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-04-06 |
4 |
B |
$2.24 |
$1,536,943 |
I/I |
685,676 |
17,048,370 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-04-09 |
4 |
B |
$2.43 |
$78,099 |
I/I |
32,100 |
17,080,470 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-04-10 |
4 |
B |
$2.46 |
$499,994 |
I/I |
203,200 |
17,283,670 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-05-08 |
4 |
B |
$2.13 |
$151,250 |
I/I |
70,873 |
17,354,543 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-05-17 |
4 |
B |
$2.13 |
$391,436 |
I/I |
184,179 |
17,538,722 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-05-18 |
4 |
B |
$2.14 |
$42,928 |
I/I |
20,100 |
17,558,822 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-05-21 |
4 |
B |
$2.14 |
$69,059 |
I/I |
32,200 |
17,591,022 |
1.5 |
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2018-05-25 |
4 |
A |
$4.00 |
$3,333,332 |
I/I |
833,333 |
3,082,186 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-05-30 |
4 |
B |
$2.15 |
$591 |
I/I |
275 |
17,591,297 |
1.42 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|